Opko Health, Inc.

Schering Corporation

Sapna S Shah

Neng-Yang Shih

Anandan Palani

Xianhai Huang

Dong Xiao

Sunil Paliwal

Cheng Wang

Hon-Chung Tsui

Ashwin Umesh Rao

Michelle Laci Wrobleski

Xiao Chen

A compound having the general structure shown in Formula I: or pharmaceutically acceptable salts and/or solvates thereof are useful in treating diseases or conditions mediated by NKreceptors, for example various physiological disorders, symptoms or diseases, including emesis, depression, anxiety and cough.

[object Object]

NK1 antagonists

A compound having the general structure shown in Formula I: or pharmaceutically acceptable salt and/or solvates thereof are useful in treating diseases or conditions mediated by NKreceptors, for example various physiological disorders, symptoms or diseases, including emesis, depression, anxiety and cough.

A compound having the general structure shown in Formula (I): or pharmaceutically acceptable salts and/or solvates thereof are useful in treating diseases or conditions mediated by NKreceptors, for example various physiological disorders, symptoms or diseases, including emesis, depression, anxiety and cough.

Growing community of inventors

Jamesburg, NJ, United States of America

Sapna S Shah